Global /Japan /Healthcare /Drug Manufacturers - General /4574
chevron_leftBack
Taiko Pharmaceutical Co.,Ltd. logo

Taiko Pharmaceutical Co.,Ltd.

4574
TSE: 4574 Delayed
292JPY -0.3%
1.82 USD
As of 9 June 2026, Taiko Pharmaceutical Co.,Ltd. has a market cap of $91.56M USD, ranking #26156 globally and #2319 in Japan. It ranks #2346 in the Healthcare sector, and #845 in the Drug Manufacturers - General industry.
Global Rank
26156
Country Rank
2319
Sector Rank
2346
Industry Rank
845
Key Stats
Market Cap
$91.56MUSD
14.67B JPY
Enterprise Value
$70.09MUSD
11.23B JPY
Revenue (TTM)
$39.92MUSD
6.4B JPY
EBITDA (TTM)
$4.52MUSD
724.0M JPY
Net Income (TTM)
$5.76MUSD
923.0M JPY
EBITDA Margin
11%
Profit Margin
14%
PE Ratio
15.9
Forward PE
22.6
PS Ratio
2.3
PB Ratio
1.7
EV/EBITDA
15.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Takashi Shibata open_in_new
Employees
220
Founded
1946
Website
seirogan.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -1% -3.3% 3.9% 4.7% 5.8%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4574
大幸薬品株式会社
ISIN: JP3442200006
Shares Out.:
50.251M1 Shares Float: 33.961M2
TV:
SA:
YF:
GF:
BA:
MS:
292 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Taiko Pharmaceutical Co.,Ltd.

Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.

Similar Companies

Industry: Drug Manufacturers - General (Japan)
Name
Market Cap diff.
PE
$81.54B
13.07T JPY
89K%
28.9
$52.14B
8.36T JPY
57K%
75.1
$36.79B
5.9T JPY
40K%
15.7
$30.33B
4.86T JPY
33K%
16.2
$25.78B
4.13T JPY
28K%
14.2
$16.89B
2.71T JPY
18K%
13.9
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
832K%
38.1
JNJ
$547.28B
598K%
26.4
ABBV
$360.63B
394K%
97.4
$322.98B
256.25B CHF
353K%
19.9
AZN
$288.68B
215.59B GBP
315K%
27.6
NOVN
$275.9B
218.9B CHF
301K%
20.5
chevron_leftBack